<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00701740</url>
  </required_header>
  <id_info>
    <org_study_id>UNIFESP</org_study_id>
    <nct_id>NCT00701740</nct_id>
  </id_info>
  <brief_title>Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial</brief_title>
  <official_title>Phase II Randomized Controlled Trial to Evaluate the Clinical and Histological Effects of Oral Isotretinoin for the Treatment of Photoaging on Face and Forearms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A clinical and histological randomized controlled phase II trial to evaluate the efficacy and&#xD;
      safety of oral isotretinoin for treating photoaging was performed with 32 menopausal or&#xD;
      sterilized women aged 40-55y. The subjects were included in two randomly selected groups: A-&#xD;
      21 women received 20mg oral isotretinoin 3x week, moisturizer, sunscreen SPF 60 during three&#xD;
      months; B- 11 women received only same moisturizer/sunscreen.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical assessment ranging from -2=very bad to +2=very good for all patients. Also,&#xD;
      profilometry, corneometer and skin elasticity tests in periocular regions and left forearm;&#xD;
      skin biopsy on left forearm before/after treatment in B and in 10 randomly selected patients&#xD;
      from A. Microscopic evaluation of corneal layer and epidermal thickness, dermal elastosis,&#xD;
      new collagen and p53 epidermal expression performed by quantitative digital image analysis.&#xD;
      Blind evaluations (group/time) conducted by two independent observers.&#xD;
&#xD;
      Clinical evaluation results showed no alterations (0) or slight improvement (+1) for all&#xD;
      patients; profilometry, corneometer and skin elasticity measurements presented a significant&#xD;
      difference in pre and post treatment values (p=0,001 to 0,028) with no differences between&#xD;
      A/B. Regarding histological findings and p53 expression no previous differences between&#xD;
      groups before the treatment were observed (p&gt;0,1).Quantitative microscopic digital analysis&#xD;
      demonstrated no differences between groups at the end of the study for the majority of&#xD;
      variables. However, slight but significant difference between A/B subjects was found for p53&#xD;
      with major expression reduction for those treated with oral isotretinoin [0,66±0,31 vs&#xD;
      0,94±0,34 respectively (p=0,04)]. The main side effects were cheilitis in 15 patients (75%)&#xD;
      and xerophthalmia in 5 (25%). No significant alterations occurred in biochemical tests.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>histological findings</measure>
    <time_frame>before and after 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>laboratory tests</measure>
    <time_frame>before, after 1 and 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Photoaging</condition>
  <condition>Epidermal p53 Expression</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A - 21 subjects were treated 20mg isotretinoin 3/week plus moisturizer and sunscreen,for three months; 10 randomly selected were submitted to skin biopsies before and after the end of treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>11 subjects received only the same moisturizer/sunscreen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral isotretinoin and Mexoryl SX / XL</intervention_name>
    <description>20mg, 3/week,continuously for three months</description>
    <arm_group_label>A</arm_group_label>
    <other_name>isotretinoin</other_name>
    <other_name>mexoryl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mexoryl XL / SX</intervention_name>
    <description>11 subjects used only the same moisturizer and SPF 60 sunscreen</description>
    <arm_group_label>B</arm_group_label>
    <other_name>mexoryl</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  menopausal or sterilized women&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  woman at risk of pregnancy, with alterations on liver function or lipid profile&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edileia Bagatin, MD, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal University of Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04023-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>June 18, 2008</study_first_submitted>
  <study_first_submitted_qc>June 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <last_update_submitted>August 13, 2018</last_update_submitted>
  <last_update_submitted_qc>August 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Edileia Bagatin</investigator_full_name>
    <investigator_title>Edileia Bagatin</investigator_title>
  </responsible_party>
  <keyword>photoaging</keyword>
  <keyword>isotretinoin</keyword>
  <keyword>profilometry</keyword>
  <keyword>digital analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Isotretinoin</mesh_term>
    <mesh_term>Terephthalylidene dicamphor sulfonic acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

